Transcranial Magnetic Stimulation (TMS): A Noninvasive Option When Depression Has Not Improved Enough
What Is Transcranial Magnetic Stimulation (TMS)?
TMS uses an electromagnetic coil placed against the scalp to generate rapidly changing magnetic fields. These magnetic pulses induce small electrical currents in targeted areas of the brain, which can influence neural circuits involved in mood, cognition, and other functions. TMS does not require surgery or an implanted device, and patients usually remain awake during treatment.
For depression, TMS commonly targets regions of the prefrontal cortex that are involved in mood regulation. Research shows that repetitive TMS (rTMS) can change activity within relevant brain networks, although the full mechanisms responsible for its therapeutic effects continue to be studied.
In the United States, different TMS systems have received FDA clearance for specific indications. The cleared condition, age range, stimulation method, and treatment protocol can vary by device. Therefore, saying that “TMS is FDA-cleared” does not mean every TMS system is cleared to treat every mental health condition. A qualified clinician must determine whether a particular device and protocol are appropriate for an individual patient.



Who May Be Evaluated for TMS?
TMS is most commonly considered for depression, particularly when prior treatment has not provided enough improvement. You may discuss TMS with a clinician if you:
TMS candidacy cannot be determined only by the number of medications you have tried or by a single symptom. Your clinician will also consider whether the diagnosis is accurate, whether bipolar disorder or another condition may be present, your current medications and medical health, seizure risk, implanted devices, and other safety considerations. Insurance requirements and prior-authorization criteria may also differ from clinical eligibility.
What Happens Before TMS Treatment?
What Are the Common Side Effects and Risks of TMS?
TMS is generally well tolerated, but “noninvasive” does not mean risk-free. Common side effects can include:
These effects may be more noticeable early in treatment, and some patients become more comfortable as treatment continues. The treatment team may adjust stimulation settings or recommend other measures when appropriate.
Seizure is an uncommon but important risk. In people with bipolar disorder, TMS may also carry a risk of mood elevation, including mania or hypomania. Tell the care team promptly if you develop a substantially decreased need for sleep, unusually elevated or irritable mood, impulsivity, or other changes that are different from your usual baseline. Hearing protection is also typically used according to device and clinic safety procedures.
Who Needs Additional Safety Review Before TMS?
Before treatment, tell the care team if you have:
Having an implant does not automatically mean you cannot receive TMS. Safety depends on the device type, location, magnetic characteristics, and the TMS system being used. The clinical team should make this determination individually.



